Volume 45, Issue 7 e70150
LETTER TO THE EDITOR

Expanding Perspectives on FIB-4 as a Predictor of Hepatic and Extrahepatic Malignancy Risk

Yuning Wang

Yuning Wang

Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for more papers by this author
Yufei Huang

Yufei Huang

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Search for more papers by this author
Shuhang Wang

Corresponding Author

Shuhang Wang

Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Correspondence:

Shuhang Wang ([email protected])

Ning Li ([email protected])

Search for more papers by this author
Ning Li

Corresponding Author

Ning Li

Clinical Trial Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Correspondence:

Shuhang Wang ([email protected])

Ning Li ([email protected])

Search for more papers by this author
First published: 17 June 2025
Citations: 1

Funding: This work was supported by the grant Beijing Municipal Health Commission (Beijing Demonstration Research Ward BCRW20200303); National Natural Science Foundation of China (82272951, 82272953); Chinese Academy of Medical Sciences (2022-I2M-C&T-B-070); National Key Research and Development Program of China (Grant No. 2023YFC2508500).

Yuning Wang and Yufei Huang have contributed equally to this work.

No abstract is available for this article.

Data Availability Statement

The authors have nothing to report.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.